cotinine has been researched along with oxidopamine in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hermida-Ameijeiras, A; Labandeira-García, JL; López-Real, AM; Méndez-Alvarez, E; Soto-Otero, R | 1 |
| Huang, LZ; Quik, M; Riveles, K | 1 |
| Bordia, T; Huang, LZ; Michael McIntosh, J; Parameswaran, N; Quik, M | 1 |
| Grady, SR; Huang, LZ; Quik, M | 1 |
4 other study(ies) available for cotinine and oxidopamine
| Article | Year |
|---|---|
Effects of (-)-nicotine and (-)-cotinine on 6-hydroxydopamine-induced oxidative stress and neurotoxicity: relevance for Parkinson's disease.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Corpus Striatum; Cotinine; Disease Models, Animal; Drug Interactions; Female; Male; Neurotoxicity Syndromes; Nicotine; Nicotinic Agonists; Oxidative Stress; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley | 2002 |
Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells.
Topics: Bridged Bicyclo Compounds, Heterocyclic; Catecholamines; Cell Count; Cell Differentiation; Cell Line; Cell Survival; Cotinine; Humans; Immunohistochemistry; Neuroprotective Agents; Nicotiana; Nicotine; Nicotinic Agonists; Oxidopamine; Phenotype; Pyridines; Receptors, Nicotinic; Smoke; Smoking; Tyrosine 3-Monooxygenase | 2008 |
Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Analysis of Variance; Animals; Autoradiography; Cocaine; Conotoxins; Corpus Striatum; Cotinine; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Iodine Isotopes; Male; Motor Activity; Neuroprotective Agents; Neurotoxicity Syndromes; Nicotine; Oxidopamine; Protein Binding; Rats; Rats, Sprague-Dawley; Saimiri; Substantia Nigra; Time Factors | 2009 |
Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors.
Topics: Animals; Antiparkinson Agents; Autoradiography; Bridged Bicyclo Compounds, Heterocyclic; Corpus Striatum; Cotinine; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Functional Laterality; Levodopa; Mice; Mice, Inbred C57BL; Mice, Knockout; Nicotine; Nicotinic Agonists; Oxidopamine; Pyridines; Receptors, Nicotinic; Substantia Nigra; Sympatholytics | 2011 |